Precancerous Cervical Lesion Among Adult Women With Human Immune Deficiency Virus on Anti Retroviral Therapy At Saint Peter Specialized Hospital, Ethiopia: A Hospital-Based Cross-Sectional Study.

ART Ethiopia HIV precancerous cervical lesion prevalence

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 01 04 2022
accepted: 31 05 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 13 8 2022
Statut: epublish

Résumé

Cervical cancer is the fourth most frequent cancer in women representing 6.6% of all female cancers occurring in low and middle-income countries, where resources for cancer prevention programs are often scarce. So this study aimed to assess the prevalence of precancerous cervical lesion and associated factors among adult women with human immune deficiency virus (HIV) on Anti Retroviral Therapy (ART) at Saint Peter Specialized Hospital, Addis Ababa, Ethiopia. An institution-based cross-sectional study was conducted from November 06 to July 20, 2020 among 267 adult women with HIV on Anti Retroviral Therapy At Saint Peter Specialized Hospital, Ethiopia. Data were collected using face-to-face interview, patient chart review, and the examination of the squamo-columnar junction by the visual inspection with the acetic acid method. The collected data were entered into Epi-data version 3.1 and exported to Statistical Package for the Social Sciences (SPSS) version 24.0 for analysis. Bivariate and multivariable binary logistic regression analysis were used to identify factors associated with the precancerous cervical lesion. Statistical significance was considered at a P-valve less than 0.05. A total of 267 women who were on ART were included in the study and the prevalence of precancerous cervical lesion was 7.5% with 95% CI =4.10%-10.50%. Modern family planning (AOR = 4.14, 95% CI = 1.23-13.87), history of sexual transmission infection (STI) (AOR=5.39, 95% CI= 1.56-18.70) and viral load (AOR=20.85, 95% CI = 6.19-70.25) had significant association with precancerous cervical lesion. In this study, the prevalence of precancerous cervical lesion is relatively low compared to studies in low and middle-income countries. Modern family planning, history of sexual transmitted infection, and viral load had a significant association with a precancerous cervical lesion. Hence, encouraging modern family planning, and routine screening of women for pre-cancerous cervical lesions for those with high viral load have enormous contributions to decreasing cervical cancer disease among Women with Human Immune Deficiency Virus through Anti Retroviral Therapy.

Sections du résumé

Background UNASSIGNED
Cervical cancer is the fourth most frequent cancer in women representing 6.6% of all female cancers occurring in low and middle-income countries, where resources for cancer prevention programs are often scarce. So this study aimed to assess the prevalence of precancerous cervical lesion and associated factors among adult women with human immune deficiency virus (HIV) on Anti Retroviral Therapy (ART) at Saint Peter Specialized Hospital, Addis Ababa, Ethiopia.
Methods UNASSIGNED
An institution-based cross-sectional study was conducted from November 06 to July 20, 2020 among 267 adult women with HIV on Anti Retroviral Therapy At Saint Peter Specialized Hospital, Ethiopia. Data were collected using face-to-face interview, patient chart review, and the examination of the squamo-columnar junction by the visual inspection with the acetic acid method. The collected data were entered into Epi-data version 3.1 and exported to Statistical Package for the Social Sciences (SPSS) version 24.0 for analysis. Bivariate and multivariable binary logistic regression analysis were used to identify factors associated with the precancerous cervical lesion. Statistical significance was considered at a P-valve less than 0.05.
Result UNASSIGNED
A total of 267 women who were on ART were included in the study and the prevalence of precancerous cervical lesion was 7.5% with 95% CI =4.10%-10.50%. Modern family planning (AOR = 4.14, 95% CI = 1.23-13.87), history of sexual transmission infection (STI) (AOR=5.39, 95% CI= 1.56-18.70) and viral load (AOR=20.85, 95% CI = 6.19-70.25) had significant association with precancerous cervical lesion.
Conclusion UNASSIGNED
In this study, the prevalence of precancerous cervical lesion is relatively low compared to studies in low and middle-income countries. Modern family planning, history of sexual transmitted infection, and viral load had a significant association with a precancerous cervical lesion. Hence, encouraging modern family planning, and routine screening of women for pre-cancerous cervical lesions for those with high viral load have enormous contributions to decreasing cervical cancer disease among Women with Human Immune Deficiency Virus through Anti Retroviral Therapy.

Identifiants

pubmed: 35957869
doi: 10.3389/fonc.2022.910915
pmc: PMC9361014
doi:

Types de publication

Journal Article

Langues

eng

Pagination

910915

Informations de copyright

Copyright © 2022 Zelalem, Weldegebreal, Ayele, Deressa, Debella, Eyeberu, Hassen and Dessie.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Braz J Infect Dis. 2012 Mar-Apr;16(2):164-9
pubmed: 22552459
BMC Res Notes. 2018 Feb 20;11(1):145
pubmed: 29463299
Int J Health Sci (Qassim). 2019 May-Jun;13(3):4-9
pubmed: 31123433
BMC Cancer. 2015 Jul 24;15:541
pubmed: 26205980
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:28-44
pubmed: 34669203
Lancet Glob Health. 2020 Feb;8(2):e191-e203
pubmed: 31812369
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
BMC Clin Pathol. 2015 Sep 23;15:16
pubmed: 26401120
Infect Agent Cancer. 2019 Nov 11;14:36
pubmed: 31737087
AIDS Res Treat. 2012;2012:953743
pubmed: 22548156
J Oncol. 2016;2016:5473681
pubmed: 27478441
PLoS One. 2018 Jan 19;13(1):e0191506
pubmed: 29352278
Ethiop Med J. 2015 Jul;Suppl 2:17-24
pubmed: 26591279
BMC Public Health. 2013 Jun 14;13:582
pubmed: 23767681
Pan Afr Med J. 2022 Apr 06;41:276
pubmed: 35784594
Int J Cancer. 2017 Apr 15;140(8):1850-1859
pubmed: 28108997

Auteurs

Wondimu Zelalem (W)

School of Public Health, Saint Peter Specialized Hospital, Addis Ababa, Ethiopia.

Fitsum Weldegebreal (F)

School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Behailu Hawulte Ayele (BH)

Department of Public Health and Health Policy, School of Public Health, Haramaya University, Harar, Ethiopia.

Alemayehu Deressa (A)

Department of Public Health and Health Policy, School of Public Health, Haramaya University, Harar, Ethiopia.

Adera Debella (A)

School of Nursing and Midwifery, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Addis Eyeberu (A)

School of Nursing and Midwifery, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Fila Ahmed Hassen (FA)

Department of Public Health and Health Policy, School of Public Health, Haramaya University, Harar, Ethiopia.

Yadeta Dessie (Y)

Department of Public Health and Health Policy, School of Public Health, Haramaya University, Harar, Ethiopia.

Classifications MeSH